U
ONCY

UBS’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

UBS’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-9,400
Closed -$15K – 11232
2013
Q4 		$15K Sell
9,400
-14,700
-61% -$33.1K ﹤0.01% 8550
2013
Q3 		$59K Buy
24,100
+23,100
+2,310% +$63.9K ﹤0.01% 6660
2013
Q2 		$3K Buy
+1,000
New +$2.77K ﹤0.01% 9706

Other funds holding ONCY

1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

UBS's ONCY Position: Q3 2014 in Review

UBS increased its ONCOLYTICS BIOTECH INC (ONCY) stake by 388% in Q3 2014, buying an estimated $10.1K and bringing the position to 10,020 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #9384.

UBS first reported a position in ONCY in Q2 2013 and has held it in 6 quarters since. The position peaked at $54K in Q2 2013. 30 funds tracked by Wall St. Rank hold ONCY as of Q3 2014.

  • UBS held 10,020 shares of ONCOLYTICS BIOTECH INC worth $6K as of Q3 2014.
  • UBS bought 7,965 ONCOLYTICS BIOTECH INC shares in Q3 2014, an estimated $10.1K.
  • ONCOLYTICS BIOTECH INC made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9384 holding.
  • UBS first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and has held it in 6 quarters since.
  • UBS's ONCOLYTICS BIOTECH INC position peaked at $54K in Q2 2013.
  • 30 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.